Wondering if Abbott Laboratories is undervalued, fairly priced, or perhaps even a hidden bargain? You are not alone, as many ...
Key Insights Significantly high institutional ownership implies Abbott Laboratories' stock price is sensitive to ...
The win is Abbott’s third in a row in federal court in Chicago where hundreds of cases over specialized formulas for preterm ...
StockStory.org on MSN
Q3 Earnings Outperformers: Abbott Laboratories (NYSE:ABT) And The Rest Of The Medical Devices & Supplies - Diversified Stocks
Looking back on medical devices & supplies - diversified stocks’ Q3 earnings, we examine this quarter’s best and worst ...
Zacks Investment Research on MSN
Investors Heavily Search Abbott Laboratories (ABT): Here is What You Need to Know
Abbott (ABT) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of ...
Abbott Laboratories has won a legal case claiming its Similac infant formula caused the death of a baby from necrotizing ...
According to Benzinga Pro, Abbott Laboratories's peer group average for short interest as a percentage of float is 5.57%, ...
The fate of hundreds of pending cases against Abbott and Mead Johnson hang in the balance with the latest dismissal.
Fintel reports that on October 17, 2025, Barclays maintained coverage of Abbott Laboratories (NYSE:ABT) with a Overweight ...
Walmart will become the first U.S. retailer to sell Abbott Laboratories' over-the-counter continuous glucose monitor Lingo in ...
The court said D.B.'s parents could not meet the threshold for a product liability claim under Louisiana's Products Liability ...
Abbott Laboratories closed 10.54% short of its 52-week high of $141.23, which the company achieved on March 4th.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback